| P2093 | author name string | Anju T Peters | |
| | Tetsuo Himi | |
| | Whitney W Stevens | |
| | David B Conley | |
| | Robert C Kern | |
| | Atsushi Kato | |
| | Leslie C Grammer | |
| | Robert P Schleimer | |
| | Bruce K Tan | |
| | Kathryn E Hulse | |
| | Noriko Ogasawara | |
| | Ken-Ichi Takano | |
| | Kevin C Welch | |
| | Aiko I Klingler | |
| | Julie A Poposki | |
| | Stephanie S Smith | |
| P2860 | cites work | TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers | Q37721441 |
| | Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps. | Q41506242 |
| | Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial | Q48745227 |
| | GITR co-signal in ILC2 controls allergic lung inflammation | Q50086910 |
| | Helminth Infections: Recognition and Modulation of the Immune Response by Innate Immune Cells. | Q54986943 |
| | The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms | Q57181214 |
| | Group 2 Innate Lymphoid Cells in Airway Diseases | Q91975039 |
| | Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases | Q92263907 |
| P433 | issue | 1 | |
| P304 | page(s) | 437-440.e8 | |
| P577 | publication date | 2019-09-14 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | TNF induces production of type 2 cytokines in human group 2 innate lymphoid cells | |
| P478 | volume | 145 | |